HomeFUNDING

Category: FUNDING

Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.

Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.

Phenomix Sciences Raises $7.8M in...

May 16, 2024

Funding will accelerate the commercialization and adoption of the MyPhenome™ test in the obesity specialist market and the wider industry. The MyPhenome test equips physicians with essential tools to develop effective treatment plans including lifestyle and diet intervention as well as medication and/or procedure recommendations reports Phenomix Sciences.

R3 Vascular Announces $87 Million...

May 9, 2024

R3 Vascular will use the proceeds to support the ELITE FDA IDE pivotal trial of its best-in-class bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD.

Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine

May 16, 2024

Eko Raises $65 Million in Series C Funding to Close the Gap Between Virtual and In-Person Heart and Lung Care

The new funding will be used to expand in-clinic use of the company’s platform of telehealth and AI algorithms for disease screening, and to launch a monitoring program for cardiopulmonary patients at home.

November 9, 2020

Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III

The €125 million capital raised was sourced from major domestic and international institutional investors, including fund of funds, sovereign funds, corporate investors and family offices.

November 3, 2020

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The company notes employees received, in the aggregate, options to purchase 20,835 shares of Sarepta's common stock, and in the aggregate, 8,385 restricted stock units.

November 2, 2020

Shoulder Innovations Reports Equity Financing of $21.6M

The fundraising was led by US Venture Partners together with Lightstone Ventures, also included participation by Alumni Venture Partners, Wakestream Ventures, Biosciences Research, and Commercialization Center of Western Michigan University, Invest Michigan, and the Michigan Angel Fund, among others.

November 2, 2020

Advanced Chemotherapy Technologies Achieves $5.5M Series A Financing: Company to Pursue First Clinical Trials of ACT-IOP-003 Targeting Advanced Pancreatic Cancer

The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local chemotherapy system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer.

October 29, 2020

One Health Company Secures $10M In New Financing

The new financing will enable One Health Company to accelerate the expansion of its flagship product, FidoCure®, in a time where pets are increasingly family members and demand for pet care solutions has boomed.

October 29, 2020

Sidekick Health Raises $20M in Series A Funding

Sidekick Health specializes in the creation of gamified digital therapeutic solutions and programs, transforming chronic and lifestyle disease management across multiple therapeutic areas, ranging from diabetes to ulcerative colitis and smoking cessation.

October 28, 2020

ABM Respiratory Care Raises $10.3M in Series A Funding Round: Company to Advance Commercialization in the US

The company also announced the appointment of Peter H. Soderberg as Chairman of the company's Board of Directors.

October 27, 2020

Bioneb Pvt Secures GBP £ 220 Million Capital Commitment From the Gem Group

Bioneb will use the funds to continue its research and development of its FDA-approved ultrasonic vibrating mesh drug delivery devices, medical formulations and FDA clinical trials.

October 26, 2020